(Q48663701)

English

Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats.

scientific article published on 11 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

Gabriel R. Fries

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

Flávio Kapczinski

5

object named as

Flávio Kapczinski

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

Gislaine Zilli Réus

1

object named as

Gislaine Z Réus

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

Roberto B Stringari

3

object named as

Roberto B Stringari

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

Helena Mendes Abelaira

2

object named as

Helena M Abelaira

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

publication date

11 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

Metabolic Brain Disease

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

27

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

175-182

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

https://scigraph.springernature.com/pub.10.1007/s11011-012-9281-2

0 references

Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Evidence for the involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Neurotrophins and depression

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Anhedonia and activity deficits in rats: impact of post-stroke depression

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Creatine kinase levels in patients with bipolar disorder: depressive, manic, and euthymic phases.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

An open-label, flexible-dose study of memantine in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Emerging role of glutamate in the pathophysiology of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

The role of glutamate on the action of antidepressants

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Adult brain neurogenesis and psychiatry: a novel theory of depression

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

An involvement of BDNF and PI3-K/Akt in the anti-apoptotic effect of memantine on staurosporine-evoked cell death in primary cortical neurons.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Memantine attenuates staurosporine-induced activation of caspase-3 and LDH release in mouse primary neuronal cultures

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Mechanism of action of memantine

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Animal models and human depressive disorders

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Predictability of chronic intermittent stress: effects on sympathetic-adrenal medullary responses of laboratory rats

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

The molecular neurobiology of depression

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Neurotrophic factors: from molecule to man.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Chronic mild stress paradigm reduces sweet food intake in rats without affecting brain derived neurotrophic factor protein levels

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Effects of chronic mild stress on the oxidative parameters in the rat brain.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

N-acetylcysteine for major depressive episodes in bipolar disorder

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

The cellular neurobiology of depression

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Potential antidepressive properties of amantadine, memantine and bifemelane

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Pigment epithelium-derived factor up-regulation induced by memantine, an N-methyl-D-aspartate receptor antagonist, is involved in increased proliferation of hippocampal progenitor cells

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Neurobiology of depression

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Stress, depression, and neuroplasticity: a convergence of mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Pharmacodynamics of memantine: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Acute treatment with low doses of memantine does not impair aversive, non-associative and recognition memory in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Effect of co-administration of fluoxetine and amantadine on immunoendocrine parameters in rats subjected to a forced swimming test

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Concomitant administration of fluoxetine and amantadine modulates the activity of peritoneal macrophages of rats subjected to a forced swimming test

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Glutamate-based antidepressants: 20 years on.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Stress models of depression

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9281-2

21 January 2018

Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of brain-derived neurotrophic factor is not modulated by chronic mild stress in the rat hippocampus and amygdala.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroimaging Abnormalities in the Amygdala in Mood Disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between plasma levels of glutamate, alanine and serine with severity of depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein measurement with the Folin phenol reagent

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of BDNF/TrkB signaling with NMDA receptor in learning and memory

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum glutamate in depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22327556

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11011-012-9281-2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/22327556

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48663701&oldid=1856789165"